| |
|
News
(Version:30.07.2010)
|
|
| |
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
| |
|
New: Lactobacilli in Vital Substance Microemulsion |
|
Lactobacilli for a healthy gut flora. The positive effects Lactobacilli have in the gut have been known for a long time. Now, for the first time, Veyx-Pharma have succeeded in incorporating Lactobacilli into a vital substance microemulsion. Thus the Lactobacilli can pass intact through the stomach’s gastric passage and thereby allow its full efficacy to unfold in the intestine.
Lactobacilli assist the gut flora. Gut toxins have more difficulty in damaging the intestine. Moreover, the feed conversion efficiency is better in an intact gut.
The efficacy of the Lactobacilli contained in „Bactoferm 10H11“ has been demonstrated through dung sampling in sows. Only low level burdens of Clostridium perfringens were exhibited in the animals tested compared to those that were not fed Lactobacilli.
Lactobacilli are provided in the products Veyxin® Lacto Ferm to promote gut health in pigs and in Veyxin® Lan-u-Ferm with additional „Lantharom“ to promote feed intake.
The product Veyxal® Antilax Bacto Ferm is used in piglets to maintain normal digestion and in calves, lambs and foals to maintain the water and electrolyte balance. The finely tuned complimentary components support each other in their regulatory effects in digestive disorder cases, e.g. scours.
These products are supplementary feeds and they are QS certified. |
|
| |
| |
|
|
|
|
|
| |
| |
|
New: SanDitan® Enzyme Ear Cleanser |
|
For cleansing and care of sensitive ears.
Inflammation of the ear is a frequent problem in dogs and cats. Sensitive ears can be gently cleaned regularly using the new animal care product SanDitan® Enzyme Ear Cleanser. In order for medications to reach the centre of inflammation in the ear more effectively, the removal of contaminants is recommended prior to every medicated treatment.
The well balanced combination of mild substances allows for the regular use of SanDitan® Enzyme Ear Cleanser without causing ear irritation. The ingredients are optimally harmonised and complement each other in their effects:
The enzymes chymotrypsin and trypsin (contained in pancreatin) and papain gently remove excess ear wax, dead cells, as well as products of inflammation that may be present and thus inhibit the colonisation of pathogenic organisms in the ear.
Aloe Vera, Jojoba and marigold oil (calendula) protect and provide care for the ear muscle and the outer auditory (ear) canal.
The dermatologically significant vitamins A and E promote the regeneration and rebuilding processes of the epithelium in the region of the ear. Natural resistance is strengthened. |
|
| |
| |
|
Successful piglet production |
|
First of its kind in the world. Veyx-Pharma has received the German market approval for the new pharmaceutical product for pigs to stimulate oestrus. With this patented development, the company is emphasizing its leadership role in the field of reproduction management for pigs.
“This development is based on 10 years of research with the corresponding investment“, states the proprietor Armin Heß. “We are now facing the market launch in Germany and we will be applying for market approval in the EU and in further countries“.
With this product, Veyx-Pharma offers the most comprehensive product line in the business sector providing for pig reproduction management. Hence, there is a very high degree of interest in distributing the product from other companies. Veyx-Pharma has concluded cooperation agreements with Janssen Animal Health (Division of Janssen Pharmaceutica NV) for the distribution in North, West and Southern Europe as well as with Bayer Animal Health for the distribution in America.
The product was not only developed by Veyx-Pharma but it is also entirely produced by the same group of companies from the basic raw material through to the finished pharmaceutical product. “We have the complete workflow in our own hands and have thus ensuring our competitiveness position“, states Armin Heß. “Continuous research endeavours will further strengthen and extend the market position achieved“. |
|
| |
| |